跳至主要内容
临床试验/ACTRN12606000360516
ACTRN12606000360516已完成4 期

Impact of Annual Targeted Azithromycin Treatment on Infectious Trachoma and Susceptibility to Reinfection

International Trachoma Initiative0 个研究点目标入组 3,186 人开始时间: 2006年8月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
3,186

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
6 Months 至 15 Years(—)
性别
All

入选标准

  • 1) all individuals in the SAFE, SA-only, and S-only communes were included in the study unless they were 6 months of age or younger; 2) For single dose oral azithromycin treatment at baseline and 12 months, school children aged 5-15 years who had active trachoma (defined as index case) and all members of their households regardless of active trachoma status were included for treatment in the SAFE and SA-only communes; 3) all other individuals in the SAFE, SA-only and S-only communes not in a household with an index case were included and were eligible for treatment with topical tetracycline if they had active trachoma.

排除标准

  • All children under six months of age.

研究者

相似试验